Literature DB >> 6333493

Myocardial perfusion with rubidium-82: III. Theory relating severity of coronary stenosis to perfusion deficit.

N A Mullani.   

Abstract

The relation between the quantitative perfusion deficit, as measured by emission computerized tomography, and the severity of coronary artery stenosis is important for the noninvasive clinical evaluation of coronary artery disease in man. Positron emission tomography allows direct noninvasive measurement of myocardial perfusion and quantification of the size of the perfusion defect. Given this important information, a mathematical model has been derived to gauge the severity of a coronary stenosis from quantitative perfusion measurements in the normal and poststenotic regions of the heart. The theoretical basis is presented for relating regional myocardial perfusion and regional perfusion resistance to total coronary blood flow and resistance at normal resting flow and during maximal coronary vasodilation. The concept of perfusion reserve is presented as a clinical measure of the severity of a stenosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6333493

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  PET in clinical cardiology: can we already swim?

Authors:  J A Blokland; E K Pauwels; E E van der Wall
Journal:  Eur J Nucl Med       Date:  1990

Review 2.  Detecting and assessing severity of coronary artery disease in humans.

Authors:  K L Gould
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Feb-Mar       Impact factor: 2.740

Review 3.  Myocardial scintigraphy--25 years after start.

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1988

4.  Relation between geometric dimensions of coronary artery stenoses and myocardial perfusion reserve in man.

Authors:  R A Goldstein; R L Kirkeeide; L L Demer; M Merhige; A Nishikawa; R W Smalling; N A Mullani; K L Gould
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.